Harigai, M., Tanaka, E., Inoue, E., & Sakai, R. (2024, May). Increased risk of cardiovascular events under the treatments with Janus kinase inhibitors versus biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: A retrospective longitudinal population-based study using the Japanese health insurance database. RMD Open.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Harigai, Masayoshi, Eiichi Tanaka, Eisuke Inoue, و Ryoko Sakai. "Increased Risk of Cardiovascular Events Under the Treatments with Janus Kinase Inhibitors Versus Biological Disease-modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis: A Retrospective Longitudinal Population-based Study Using the Japanese Health Insurance Database." RMD Open May. 2024.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)Harigai, Masayoshi, et al. "Increased Risk of Cardiovascular Events Under the Treatments with Janus Kinase Inhibitors Versus Biological Disease-modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis: A Retrospective Longitudinal Population-based Study Using the Japanese Health Insurance Database." RMD Open, May. 2024.